RNA (Epi)genetics in cardiovascular diseases

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Next-generation sequencing has greatly improved our knowledge of the mammalian transcriptome, identifying thousands of non-coding RNAs (ncRNAs), which are RNAs that rather than translate for proteins, have regulatory functions. Perhaps unsurprisingly, dysregulation of individual ncRNAs has been associated with the development of pathologies, including of the cardiovascular system. The best-characterized group of ncRNAs is represented by the short, highly conserved RNAs named microRNAs (miRNAs). This ncRNA species, which principally exerts an inhibitory action on gene expression, has been implicated in many cardiovascular diseases. Unfortunately, the complexity of action of other types of ncRNA, such as long ncRNAs, has somewhat hampered the study of their role in cardiovascular pathologies. A detailed characterization of the mechanism of action of these different ncRNA species would be conducive to a better understanding of the cellular processes underlying cardiovascular disease and may lead to the development of innovative therapeutic strategies. Here, we give an overview of the current knowledge on the function of ncRNAs and their roles in cardiovascular disease development, concentrating mainly on microRNAs and long ncRNAs.

Original languageEnglish
Pages (from-to)11-16
Number of pages6
JournalJournal of Molecular and Cellular Cardiology
Volume89
DOIs
Publication statusPublished - Dec 1 2015

Fingerprint

Untranslated RNA
Cardiovascular Diseases
Long Noncoding RNA
RNA
MicroRNAs
Pathology
Cardiovascular System
Transcriptome
Gene Expression
Proteins
Therapeutics

Keywords

  • Cardiovascular diseases
  • Long non-coding RNAs
  • MicroRNAs
  • RNA therapeutics

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

RNA (Epi)genetics in cardiovascular diseases. / Elia, Leonardo; Condorelli, Gianluigi.

In: Journal of Molecular and Cellular Cardiology, Vol. 89, 01.12.2015, p. 11-16.

Research output: Contribution to journalArticle

@article{ce3c1e06a33a4740b2e1a84aaac17fee,
title = "RNA (Epi)genetics in cardiovascular diseases",
abstract = "Next-generation sequencing has greatly improved our knowledge of the mammalian transcriptome, identifying thousands of non-coding RNAs (ncRNAs), which are RNAs that rather than translate for proteins, have regulatory functions. Perhaps unsurprisingly, dysregulation of individual ncRNAs has been associated with the development of pathologies, including of the cardiovascular system. The best-characterized group of ncRNAs is represented by the short, highly conserved RNAs named microRNAs (miRNAs). This ncRNA species, which principally exerts an inhibitory action on gene expression, has been implicated in many cardiovascular diseases. Unfortunately, the complexity of action of other types of ncRNA, such as long ncRNAs, has somewhat hampered the study of their role in cardiovascular pathologies. A detailed characterization of the mechanism of action of these different ncRNA species would be conducive to a better understanding of the cellular processes underlying cardiovascular disease and may lead to the development of innovative therapeutic strategies. Here, we give an overview of the current knowledge on the function of ncRNAs and their roles in cardiovascular disease development, concentrating mainly on microRNAs and long ncRNAs.",
keywords = "Cardiovascular diseases, Long non-coding RNAs, MicroRNAs, RNA therapeutics",
author = "Leonardo Elia and Gianluigi Condorelli",
year = "2015",
month = "12",
day = "1",
doi = "10.1016/j.yjmcc.2015.07.012",
language = "English",
volume = "89",
pages = "11--16",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - RNA (Epi)genetics in cardiovascular diseases

AU - Elia, Leonardo

AU - Condorelli, Gianluigi

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Next-generation sequencing has greatly improved our knowledge of the mammalian transcriptome, identifying thousands of non-coding RNAs (ncRNAs), which are RNAs that rather than translate for proteins, have regulatory functions. Perhaps unsurprisingly, dysregulation of individual ncRNAs has been associated with the development of pathologies, including of the cardiovascular system. The best-characterized group of ncRNAs is represented by the short, highly conserved RNAs named microRNAs (miRNAs). This ncRNA species, which principally exerts an inhibitory action on gene expression, has been implicated in many cardiovascular diseases. Unfortunately, the complexity of action of other types of ncRNA, such as long ncRNAs, has somewhat hampered the study of their role in cardiovascular pathologies. A detailed characterization of the mechanism of action of these different ncRNA species would be conducive to a better understanding of the cellular processes underlying cardiovascular disease and may lead to the development of innovative therapeutic strategies. Here, we give an overview of the current knowledge on the function of ncRNAs and their roles in cardiovascular disease development, concentrating mainly on microRNAs and long ncRNAs.

AB - Next-generation sequencing has greatly improved our knowledge of the mammalian transcriptome, identifying thousands of non-coding RNAs (ncRNAs), which are RNAs that rather than translate for proteins, have regulatory functions. Perhaps unsurprisingly, dysregulation of individual ncRNAs has been associated with the development of pathologies, including of the cardiovascular system. The best-characterized group of ncRNAs is represented by the short, highly conserved RNAs named microRNAs (miRNAs). This ncRNA species, which principally exerts an inhibitory action on gene expression, has been implicated in many cardiovascular diseases. Unfortunately, the complexity of action of other types of ncRNA, such as long ncRNAs, has somewhat hampered the study of their role in cardiovascular pathologies. A detailed characterization of the mechanism of action of these different ncRNA species would be conducive to a better understanding of the cellular processes underlying cardiovascular disease and may lead to the development of innovative therapeutic strategies. Here, we give an overview of the current knowledge on the function of ncRNAs and their roles in cardiovascular disease development, concentrating mainly on microRNAs and long ncRNAs.

KW - Cardiovascular diseases

KW - Long non-coding RNAs

KW - MicroRNAs

KW - RNA therapeutics

UR - http://www.scopus.com/inward/record.url?scp=84952715101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952715101&partnerID=8YFLogxK

U2 - 10.1016/j.yjmcc.2015.07.012

DO - 10.1016/j.yjmcc.2015.07.012

M3 - Article

AN - SCOPUS:84952715101

VL - 89

SP - 11

EP - 16

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

ER -